Back to Search
Start Over
A phase II trial of erlotinib and bevacizumab for patients with metastatic melanoma.
- Source :
-
Pigment cell & melanoma research [Pigment Cell Melanoma Res] 2016 Jan; Vol. 29 (1), pp. 101-3. Date of Electronic Publication: 2015 Aug 20. - Publication Year :
- 2016
- Subjects :
- Antineoplastic Combined Chemotherapy Protocols adverse effects
Bevacizumab adverse effects
Disease-Free Survival
Erlotinib Hydrochloride adverse effects
Humans
Neoplasm Metastasis
Treatment Outcome
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Bevacizumab therapeutic use
Erlotinib Hydrochloride therapeutic use
Melanoma drug therapy
Melanoma pathology
Subjects
Details
- Language :
- English
- ISSN :
- 1755-148X
- Volume :
- 29
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Pigment cell & melanoma research
- Publication Type :
- Report
- Accession number :
- 26176864
- Full Text :
- https://doi.org/10.1111/pcmr.12394